The price of this share is at 2,65$, In this post we are going to talk about the listed company Caladrius Biosciences Inc, its leaders are David J. Mazzo (President, Chief Executive Officer & Director), Gregory S. Berkin (Chief Information Officer, VP-Cybersecurity & IT), Kristen K. Buck (Chief Medical Officer), they lead it to work in Managed Health Care especially in the North America region.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 2,69$ moving between 2,61$ and 2,78$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.